ID   DPC-1
AC   CVCL_DN59
SY   DPC1; Dog Prostate Carcinoma-1
DR   Wikidata; Q54831375
RX   Patent=US20030013191;
RX   PubMed=11170126;
RX   PubMed=21882212;
RX   PubMed=26714499;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2279.
CC   Doubling time: 27 hours (PubMed=11170126).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Doberman Pinscher.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
RX   Patent=US20030013191;
RA   Cussenot O., Villette J.-M.;
RT   "Prostatic cell line and use thereof to obtain an established
RT   prostatic cancer in an animal.";
RL   Patent number US20030013191, 16-Jan-2003.
//
RX   PubMed=11170126; DOI=10.1002/1097-0045(200101)46:1<2::AID-PROS1002>3.0.CO;2-5;
RA   Anidjar M., Villette J.-M., Devauchelle P., Delisle F., Cotard J.-P.,
RA   Billotey C., Cochand-Priollet B., Copin H., Barnoux M., Triballeau S.,
RA   Rain J.-D., Fiet J., Teillac P., Berthon P., Cussenot O.;
RT   "In vivo model mimicking natural history of dog prostate cancer using
RT   DPC-1, a new canine prostate carcinoma cell line.";
RL   Prostate 46:2-10(2001).
//
RX   PubMed=21882212; DOI=10.1002/pros.21479;
RA   Anidjar M., Scarlata E., Cury F.L., Rocha J., Hamel L., Luz M.,
RA   Chevalier S.;
RT   "Refining the orthotopic dog prostate cancer (DPC)-1 model to better
RT   bridge the gap between rodents and men.";
RL   Prostate 72:752-761(2012).
//
RX   PubMed=26714499; DOI=10.1186/s13550-015-0155-6;
RA   Chevalier S., Moffett S., Turcotte E., Luz M., Chauvette L.,
RA   Derbekyan V., Scarlata E., Zouanat F., Aprikian A.G., Anidjar M.;
RT   "The dog prostate cancer (DPC-1) model: a reliable tool for molecular
RT   imaging of prostate tumors and metastases.";
RL   EJNMMI Res. 5:77.1-77.13(2015).
//